These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24616479)

  • 1. Sequence-specific alterations of epitope production by HIV protease inhibitors.
    Kourjian G; Xu Y; Mondesire-Crump I; Shimada M; Gourdain P; Le Gall S
    J Immunol; 2014 Apr; 192(8):3496-506. PubMed ID: 24616479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different antigen-processing activities in dendritic cells, macrophages, and monocytes lead to uneven production of HIV epitopes and affect CTL recognition.
    Dinter J; Gourdain P; Lai NY; Duong E; Bracho-Sanchez E; Rucevic M; Liebesny PH; Xu Y; Shimada M; Ghebremichael M; Kavanagh DG; Le Gall S
    J Immunol; 2014 Nov; 193(9):4322-4334. PubMed ID: 25230751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Protease Inhibitor-Induced Cathepsin Modulation Alters Antigen Processing and Cross-Presentation.
    Kourjian G; Rucevic M; Berberich MJ; Dinter J; Wambua D; Boucau J; Le Gall S
    J Immunol; 2016 May; 196(9):3595-607. PubMed ID: 27009491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individuals.
    Zhang SC; Martin E; Shimada M; Godfrey SB; Fricke J; Locastro S; Lai NY; Liebesny P; Carlson JM; Brumme CJ; Ogbechie OA; Chen H; Walker BD; Brumme ZL; Kavanagh DG; Le Gall S
    J Immunol; 2012 Jun; 188(12):5924-34. PubMed ID: 22586036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.
    Boucau J; Madouasse J; Kourjian G; Carlin CS; Wambua D; Berberich MJ; Le Gall S
    J Immunol; 2019 May; 202(10):2856-2872. PubMed ID: 30936293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.
    Urban S; Textoris-Taube K; Reimann B; Janek K; Dannenberg T; Ebstein F; Seifert C; Zhao F; Kessler JH; Halenius A; Henklein P; Paschke J; Cadel S; Bernhard H; Ossendorp F; Foulon T; Schadendorf D; Paschen A; Seifert U
    J Immunol; 2012 Jul; 189(2):529-38. PubMed ID: 22706083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
    Preta G; Marescotti D; Fortini C; Carcoforo P; Castelli C; Masucci M; Gavioli R
    Scand J Immunol; 2008 Dec; 68(6):579-88. PubMed ID: 19000094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
    Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
    PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope.
    Wherry EJ; Golovina TN; Morrison SE; Sinnathamby G; McElhaugh MJ; Shockey DC; Eisenlohr LC
    J Immunol; 2006 Feb; 176(4):2249-61. PubMed ID: 16455981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.
    Dinter J; Duong E; Lai NY; Berberich MJ; Kourjian G; Bracho-Sanchez E; Chu D; Su H; Zhang SC; Le Gall S
    PLoS Pathog; 2015 Mar; 11(3):e1004725. PubMed ID: 25781895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.
    Destro F; Sforza F; Sicurella M; Marescotti D; Gallerani E; Baldisserotto A; Marastoni M; Gavioli R
    Immunology; 2011 May; 133(1):105-14. PubMed ID: 21342184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portable flanking sequences modulate CTL epitope processing.
    Le Gall S; Stamegna P; Walker BD
    J Clin Invest; 2007 Nov; 117(11):3563-75. PubMed ID: 17975674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic enzymes involved in MHC class I antigen processing: A guerrilla army that partners with the proteasome.
    Lázaro S; Gamarra D; Del Val M
    Mol Immunol; 2015 Dec; 68(2 Pt A):72-6. PubMed ID: 26006050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
    Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
    J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity.
    Gavioli R; Gallerani E; Fortini C; Fabris M; Bottoni A; Canella A; Bonaccorsi A; Marastoni M; Micheletti F; Cafaro A; Rimessi P; Caputo A; Ensoli B
    J Immunol; 2004 Sep; 173(6):3838-43. PubMed ID: 15356131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.
    Sewell AK; Price DA; Teisserenc H; Booth BL; Gileadi U; Flavin FM; Trowsdale J; Phillips RE; Cerundolo V
    J Immunol; 1999 Jun; 162(12):7075-9. PubMed ID: 10358150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing the epitope flanking regions for optimal generation of CTL epitopes.
    Steers NJ; Currier JR; Jobe O; Tovanabutra S; Ratto-Kim S; Marovich MA; Kim JH; Michael NL; Alving CR; Rao M
    Vaccine; 2014 Jun; 32(28):3509-16. PubMed ID: 24795226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
    Choppin J; Cohen W; Bianco A; Briand JP; Connan F; Dalod M; Guillet JG
    J Immunol; 2001 May; 166(10):6164-9. PubMed ID: 11342637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.
    Marescotti D; Destro F; Baldisserotto A; Marastoni M; Coppotelli G; Masucci M; Gavioli R
    Immunology; 2010 Mar; 129(3):386-95. PubMed ID: 19922423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.